After The Stock Rose 3.23% Over The Week, Is Meihua International Medical Technologies Co Ltd (NASDAQ: MHUA) Still A Buy?

Meihua International Medical Technologies Co Ltd (NASDAQ:MHUA)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting 0.51. At the close of trading, the stock’s price was $0.33, to imply an increase of 0.43% or $0.0 in intraday trading. The MHUA share’s 52-week high remains $1.47, putting it -345.45% down since that peak but still an impressive 24.24% since price per share fell to its 52-week low of $0.25. The company has a valuation of $8.58M, with an average of 0.21 million shares in intraday trading volume over the past 10 days and average of 719.26K shares over the past 3 months.

Meihua International Medical Technologies Co Ltd (NASDAQ:MHUA) trade information

After registering a 0.43% upside in the last session, Meihua International Medical Technologies Co Ltd (MHUA) has traded red over the past five days. The 5-day price performance for the stock is 3.23%, and -6.25% over 30 days. With these gigs, the year-to-date price performance is -4.75%. Short interest in Meihua International Medical Technologies Co Ltd (NASDAQ:MHUA) saw shorts transact 0.22 million shares and set a 0.24 days time to cover.

MHUA Dividends

Meihua International Medical Technologies Co Ltd has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

The next major institution holding the largest number of shares is RENAISSANCE TECHNOLOGIES LLC with 24300.0 shares, or about 0.1015% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $20702.0.

Going by data provided on Nov 30, 2024 , Fidelity NASDAQ Composite Index Fund holds roughly 14.39 shares. This is just over 0.06% of the total shares, with a market valuation of $4731.0